UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Current medical research and opinion, ISSN 0300-7995, 01/2013, Volume 29, Issue 1, pp. 1 - 12
Rifabutin | Rifampin | Rifapentine | Drug interactions | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Biological and medical sciences | Medical sciences | Drug toxicity and drugs side effects treatment | Miscellaneous (drug allergy, mutagens, teratogens...) | Pharmacology. Drug treatments | Rifampin - analogs & derivatives | Simvastatin - therapeutic use | Antifungal Agents - adverse effects | Digoxin - adverse effects | Simvastatin - adverse effects | Antibiotics, Antitubercular - adverse effects | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Antifungal Agents - therapeutic use | Rifampin - adverse effects | Verapamil - therapeutic use | Drug Interactions | Verapamil - adverse effects | Rifampin - therapeutic use | Contraceptives, Oral - adverse effects | Contraceptives, Oral - therapeutic use | Digoxin - therapeutic use | HIV Protease Inhibitors - adverse effects | Rifabutin - adverse effects | Anti-Arrhythmia Agents - therapeutic use | HIV Protease Inhibitors - therapeutic use | Anticholesteremic Agents - adverse effects | Itraconazole - therapeutic use | Anticholesteremic Agents - therapeutic use | Anti-Arrhythmia Agents - adverse effects | Itraconazole - adverse effects | Antibiotics, Antitubercular - therapeutic use | Cytochrome P-450 Enzyme System - biosynthesis | Rifabutin - therapeutic use | ATP Binding Cassette Transporter, Sub-Family B | Index Medicus
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 08/2016, Volume 60, Issue 8, pp. 4530 - 4538
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antifungal Agents - pharmacology | Cryptococcus - metabolism | Antifungal Agents - adverse effects | Fluconazole - pharmacology | Tetrazoles - pharmacology | Ergosterol - metabolism | Voriconazole - adverse effects | Voriconazole - pharmacology | Humans | Clotrimazole - pharmacology | Fluconazole - adverse effects | Lanosterol - analogs & derivatives | Enzyme Activation - drug effects | Itraconazole - pharmacology | Ketoconazole - pharmacology | Pyridines - adverse effects | Clotrimazole - adverse effects | Itraconazole - adverse effects | Lanosterol - metabolism | Pyridines - pharmacology | Sterol 14-Demethylase - metabolism | Ketoconazole - adverse effects | Tetrazoles - adverse effects | Cryptococcus - drug effects | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2018, Volume 2018, Issue 8, pp. CD004773 - CD004773
HIV/AIDS | Primary Prevention | Fluconazole | HIV Seropositivity | Cryptococcosis | Other complications/co‐morbidities: treatment | CD4 Lymphocyte Count | Cause of Death | Randomized Controlled Trials as Topic | Prevention | Infectious disease | HIV | AIDS‐Related Opportunistic Infections | Candida | Antifungal Agents | Prevention: other | Medicine General & Introductory Medical Sciences | Drug Resistance, Fungal | Itraconazole | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antifungal Agents - adverse effects | HIV Seropositivity - complications | Cryptococcosis - prevention & control | Humans | Fluconazole - adverse effects | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Itraconazole - therapeutic use | AIDS-Related Opportunistic Infections - prevention & control | Itraconazole - adverse effects | Cryptococcosis - mortality | Adult | Candida - drug effects | Child | HIV Seropositivity - immunology | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 24, pp. 2329 - 2340
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antifungal Agents - adverse effects | Administration, Oral | Humans | AIDS-Related Opportunistic Infections - drug therapy | Deoxycholic Acid - therapeutic use | Male | Antifungal Agents - therapeutic use | Induction Chemotherapy - adverse effects | Amphotericin B - adverse effects | Itraconazole - therapeutic use | Creatinine - metabolism | Deoxycholic Acid - adverse effects | Itraconazole - adverse effects | AIDS-Related Opportunistic Infections - mortality | Infusions, Intravenous - adverse effects | Mycoses - drug therapy | Talaromyces - isolation & purification | Adult | Female | Mycoses - mortality | Amphotericin B - therapeutic use | Drug Combinations | Usage | Care and treatment | Amphotericin B | HIV patients | Drug therapy | HIV infection | Itraconazole | Intravenous administration | Kidneys | Anemia | Mortality | Body weight | Immune clearance | Clinical trials | Immune reconstitution | Inflammation | Fungal infections | Side effects | Fungicidal activity | Human immunodeficiency virus--HIV | Renal failure | Hypokalemia | Hypomagnesemia | Pharmaceuticals | Kidney transplantation | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 06/2019, Volume 79, Issue 8, pp. 833 - 853
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Fungicides | Transplants & implants | Fluorine | Liver | Prophylaxis | Systematic review | Fungal infections | Cancer therapies | Hematopoietic stem cells | Skin cancer | Pain | Heterocyclic compounds | Voriconazole | Hypokalemia | Hepatotoxicity | Drug dosages | Itraconazole | Gynecomastia | Squamous cell carcinoma | Hyponatremia | Baldness | Invasiveness | Antifungal agents | Pancreatitis | Fluorides | Metabolism | Hemopoiesis | Azoles | Periostitis | Alopecia | Stem cells | Posaconazole
Journal Article
American journal of health-system pharmacy, ISSN 1079-2082, 10/2011, Volume 68, Issue 19, pp. 1791 - 1804
Antifungals | Heart failure | Immunomodulating agents | Postmarketing surveillance | Toxicity | Antineoplastic agents | Cardiac drugs | Dronedarone | Tyrosine kinase inhibitors | Bevacizumab | Dutasteride | Lapatinib | Thiazolidinediones | Itraconazole | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Antifungal Agents - adverse effects | Appetite Depressants - adverse effects | Calcium Channel Blockers - adverse effects | Humans | Thiazolidinediones - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Arrhythmia Agents - adverse effects | Antineoplastic Agents - adverse effects | Pharmacy Service, Hospital | Biological Products - adverse effects | Pharmacists | Hypoglycemic Agents - adverse effects | Glucocorticoids - adverse effects | Heart Failure - chemically induced | Drugs | Complications and side effects | Care and treatment | Adverse and side effects | Development and progression | Dosage and administration | Nonsteroidal anti-inflammatory drugs | Diagnosis | Risk factors | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2007, Volume 356, Issue 4, pp. 348 - 359
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Pharmacology. Drug treatments | Antifungal agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Single-Blind Method | Triazoles - adverse effects | Antifungal Agents - adverse effects | Humans | Middle Aged | Fluconazole - adverse effects | Male | Opportunistic Infections - prevention & control | Leukemia, Myeloid, Acute - complications | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Antineoplastic Agents - adverse effects | Neutropenia - mortality | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Neutropenia - chemically induced | Myelodysplastic Syndromes - drug therapy | Triazoles - therapeutic use | Mycoses - prevention & control | Kaplan-Meier Estimate | Treatment Outcome | Myelodysplastic Syndromes - complications | Neutropenia - drug therapy | Itraconazole - therapeutic use | Leukemia, Myeloid, Acute - mortality | Itraconazole - adverse effects | Adolescent | Myelodysplastic Syndromes - mortality | Aged | Mycoses - mortality | Fluconazole | Comparative analysis | Fungi | Infections | Fungal infections | Mortality | Index Medicus | Abridged Index Medicus
Journal Article